SPP1 and metabolic dysfunction-associated steatohepatitis: Hepatocyte CEBPA is gradually lost during nonalcoholic steatohepatitis in humans, which leads to hepatocyte-derived osteopontin release that in turn enhances liver fibrosis progression.